NCT00955305 2018-06-06Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-small Cell Lung CancerNational Cancer Institute (NCI)Phase 2 Terminated175 enrolled 8 charts